Serum calcitonin levels with calcium loading tests before and after total thyroidectomy in patients with thyroid diseases other than medullary thyroid carcinoma

Endocrine Journal

Volumn 58, Issue 3, 2011, Pages 217-221

  Kudo, Takumi ^a   Miyauchi, Akira ^a   Ito, Yasuhiro ^a   Yabuta, Tomonori ^a   Inoue, Hiroyuki ^a   Higashiyama, Takuya ^a   Tomoda, Chisato ^a   Hirokawa, Mitsuhide ^a   Amino, Nobuyuki ^a  

^a KUMA HOSPITAL   (Japan)

Author keywords

Calcitonin; Calcium test; Calcium loading test; Medullary thyroid carcinoma; Thyroidectomy

Indexed keywords

CALCITONIN; GLUCONATE CALCIUM;

ADOLESCENT; ADULT; CALCITONIN BLOOD LEVEL; CHILD; CLINICAL ARTICLE; EARLY DIAGNOSIS; ENDOCRINE FUNCTION TEST; FEMALE; GOITER; GRAVES DISEASE; HUMAN; MALE; MINIMAL RESIDUAL DISEASE; NOTE; SCHOOL CHILD; THYROID DISEASE; THYROID FOLLICULAR CARCINOMA; THYROID MEDULLARY CARCINOMA; THYROID PAPILLARY CARCINOMA; THYROIDECTOMY;

ADULT; CALCITONIN; CALCIUM GLUCONATE; CARCINOMA, MEDULLARY; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM, RESIDUAL; THYROID DISEASES; THYROID GLAND; THYROID NEOPLASMS; THYROIDECTOMY; TUMOR MARKERS, BIOLOGICAL;

EID: 79953308716     PISSN: 09188959     EISSN: 13484540     Source Type: Journal    
DOI: 10.1507/endocrj.K10E-359     Document Type: Note

References (19)

1. Ball DW, Baylin SB, de Bustros AC (2001) Medullary thyroid carcinoma. THYROID In: Braverman LE and Utiger RD. 8th ed. Lippincott Williams & Wilkins. Philadelphia: 930-943.
2. Mulligan LM, Kwok JB, Healey CS, Elsdon MJ, Eng C, Gardner E, Love DR, Mole SE, Moore JK, Papi L, Ponder MA, Telenius H, Tunnacliffe A, Ponder BA (1993) Germ-line mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2A. Nature 363: 458-460.
3. Donis-Keller H, Dou S, Chi D, Carlson KM, Toshima K, Lairmore TC, Howe JR, Moley JF, Goodfellow P, Wells Jr SA (1993) Mutations in the RET proto-oncogene are associated with MEN2A and FMTC. Hum Mol Genet 2: 851-856.
4. Carlson KM, Dou S, Chi D, Scavarda N, Toshima K, Jackson CE, Wells Jr SA, Goodfellow PJ, Donis-Keller H (1994) Single missense mutation in the tyrosine kinase catalytic domain of the RET protooncogene is associated with multiple endocrine neoplasia type 2B. Proc Natl Acad Sci USA 91: 1579-1583.
5. Bugalho MJM, Santos JR, Sobrinho L (2005) Preoperative diagnosis of medullary thyroid carcinoma: Fine needle aspiration cytology as compared with serum calcitonin measurement. J Surg Oncol 91: 56-60.
6. Rodding AH, Levine SN, Fowler MR (2000) Normal preoperative calcitonin levels do not always exclude medullary thyroid carcinoma in patients with large palpable thyroid masses. Thyroid 10: 919-922.
7. Hamy A, Pessaux P, Mirallie E, Mucci-Hennekinne S, Gibelin H, Mor-Martinez C, de Calan L, Ronceray J, Kraimps JL (2005) Central neck dissection in the management of sporadic medullary thyroid microcarcinoma. Eur J Sur Oncol 31: 774-777.
8. Melvin KEW, Miller HH, Tashjian AH (1971) Early diagnosis of medullary carcinoma of the thyroid gland by means of calcitonin assay. N Engl J Med 285, 1115.
9. Parthemore JG, Bronzert D, Roberts G (1974) A short calcium infusion in the diagnosis of medullary thyroid carcinoma. J Clin Endocrinol Metab 39: 108.
10. Rude RK, Singer FR (1977) Comparison of serum calcitonin levels after a one-minute calcium injection and after pentagastrin injection in the diagnosis of medullary thyroid carcinoma. J Clin Endocrinol Metab 44: 980.
11. Wells SA, Cooper CW, Ontjes DA (1975) Stimulation of thyrocalcitonin secretion by ethanol in patient with medullary thyroid carcinoma-An effect apparently not mediated by gastrin Metabolism 24: 1215.
12. Wells SA, Baylin SB, Linehan WM, Farrell RE, Cox EB, Cooper CW (1978) Provocative agents and the diagnosis of medullary carcinoma of the thyroid gland. Ann Surg 188: 139-141.
13. Gimm O, Ukkat J, Dralle H (1998) Determinative factors of biochemical cure after primary and reoperative surgery for sporadic medullary thyroid carcinoma. World J Surg 22: 562-568.
14. Miyauchi A, Matuzuka F, Hirai K, Yokozawa T, Kobayashi K, Kuma S, Kuma K, Futami H, Yamaguchi K (2000) Unilateral surgery supported by germline RET oncogene mutation analysis in patients with sporadic medullary thyroid carcinoma. World J Surg 24: 1367-1372.
15. De Groot JWB, Plukker JTM, Wolffenbuttelt BHR, Wiggers T, Sluiter WJ, Links TP (2006) Determinants of life expectancy in medullary thyroid cancer: age does not matter. Clinical Endocrinol 65: 729-736.
16. Micolli P, Minuto MN, Ugolini C, Molinaro E, Basolo F, Berti P, Pinchera A, Elisei R (2007) Clinically unpredictable prognostic factors in the outcome of medullary thyroid cancer. Endocrine-Related Cancer 14: 1099-1105.
17. Lips CJ, Landsvater RM, Hoppener JW, Geerdink RA, Blijham G, van Veen JM, van Gils A, de Wit MJ, Zewald RA, Berends M, Beemer FA, Brouwers-Smalbraak J, Jansen R, van Amstel HKP, van Vroonhoven T, Vroom TM (1994) Clinical screening as compared with DNA analysis in families with multiple endocrine neoplasia type 2A. N Engl J Med 331: 828-835.
18. Gibelin J. Essique D, Jones C, Levillain P, Marechaud R, Kraimps JL (2005) Increased calcitonin level in thyroid nodules without medullary carcinoma. Br J Surg 92: 574-578.
19. Kudo T, Miyauchi A, Ito Y, Amino N, Hirokawa M (2007) Diagnosis of medullary thyroid carcioma by calcitonin measurement in fine-needle aspiration biopsy specimens. Thyroid 17: 635-638.